ArticleThe Journal of biological chemistry2016

Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.